At present, the measures predicting neurological outcomes after cardiac arrest include neuroelectrophysiology (electroencephalography, somatosensory evoked potential, etc.), imaging examination (CT, cranial magnetic resonance, optic nerve sheath diameter measurement), physical examination, and biological markers (NSE, tau protein, etc.). The gene discussed is MAPT; the disease is cardiac arrest.